Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

T cell expansion technology: an interview with Alexander Malykhin, CVPF, University of Pennsylvania

T cells are taken from the patient’s blood and then modified using lentivirus, adenovirus or RNA electroporation.

From Beckman Coulter Life Sciences - Flow Cytometry 5 May 2015

GNC Holdings reports consolidated revenue of $670.2 million for first quarter 2015

GNC Holdings, Inc., a leading global specialty health, wellness and performance retailer, today reported its financial results for the quarter ended March 31, 2015.

30 Apr 2015

HeartWare International's revenue increases 5% to $70.0 million in first quarter 2015

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $70.0 million for the first quarter ended March 31, 2015, a five percent increase compared to $66.5 million in revenue for the same period of 2014.

30 Apr 2015

GE Healthcare’s first Innovation Village in the UK creates international interest from young life science businesses

Edwina Hart, Welsh Minister for Economy, Transport and Science and Kieran Murphy, President and CEO of GE Healthcare Life Sciences, opened the first phase of GE Healthcare’s new campus for growing businesses developing tools and technologies for the global life sciences industry on 27th April.

29 Apr 2015

Sangamo BioSciences to present data on ZFP Therapeutic platform at ASGCT meeting

Sangamo BioSciences, Inc. announced that data from clinical, preclinical and research-stage programs focused on the development of ZFP Therapeutics will be presented at the 18th Annual Meeting of the American Society of Gene and Cell Therapy

29 Apr 2015

Two UWM sensors offer protection against threat of contaminated water supplies

About 13.2 million households in the United States obtain their water from private wells, a method that offers no assurances of the water's quality. Testing private wells can be expensive and results can take weeks.

29 Apr 2015

IDT opens molecular biology R&D facility in Redwood City

Already the world’s leader in custom nucleic acid synthesis, Integrated DNA Technologies (IDT) is capitalizing on its expertise to deliver a broader range of validated molecular biology products. Research and development for these products will now be performed in a newly built facility in Redwood City, California.

From Integrated DNA Technologies 28 Apr 2015

Stempeutics Research granted process patent in China for novel stem-cell based drug Stempeucel

Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced today that the State Intellectual Property Office of China granted a process patent for its novel stem-cell based drug Stempeucel.

28 Apr 2015

Resverlogix, Hepalink announce equity investment and license agreement for RVX-208

Resverlogix Corp. today announced that it has entered into a Framework Agreement which sets forth the principal business terms for an equity investment and a license of RVX-208, for all indications, to Shenzhen Hepalink Pharmaceutical Co., Ltd. for China, Hong Kong, Taiwan and Macau (the "Territories").

27 Apr 2015

Haemonetics' revenue for fourth quarter fiscal 2015 down 6%

Haemonetics Corporation today reported revenue for the fourth quarter fiscal 2015 of $226.5 million, down 6%. Excluding currency impact, revenue was down 4% in the quarter. The Company reported a fourth quarter GAAP net loss of $2.9 million or $0.06 per share.

27 Apr 2015

OncoGenex terminates agreement with Teva, regains rights to custirsen

OncoGenex Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, OncoGenex Technologies Inc., executed a termination agreement with Teva Pharmaceuticals Ltd. under which OncoGenex will regain rights to custirsen, an investigational compound currently in Phase 3 clinical development as a treatment for prostate and lung cancers.

27 Apr 2015

New study shows 'alarming rise' in costs of MS drugs over last 20 years

A new study shows an "alarming rise" over the last 20 years in the costs of drugs used to slow the progression of multiple sclerosis or reduce the frequency of attacks, according to a study led by researchers at Oregon Health & Science University and Oregon State University.

25 Apr 2015

Glide's solid dose formulation of teriparatide achieves successful results in pre-clinical study

Glide Technologies, the development company focused on solid dose formulations of therapeutics and vaccines and non-invasive diagnostics, today announced that its novel solid dose formulation of teriparatide (parathyroid hormone) achieved successful results in a pre-clinical proof-of-concept study comparing it with the currently marketed liquid product (Forteo/Forsteo).

24 Apr 2015

Glide's solid dose formulation of teriparatide achieves successful results in pre-clinical study

24 Apr 2015

Physical forces can affect development of limbs in embryos

University of Toronto engineers and a pediatric surgeon have joined forces to discover that physical forces like pressure and tension affect the development of limbs in embryos--research that could someday be used to help prevent birth defects.

23 Apr 2015

Rising shortages of key antibiotics raise serious concerns about effects on patient care

Shortages of key antibiotics, including gold-standard therapies and drugs used to treat highly resistant infections, are on the rise, according to a new study of shortages from 2001 to 2013 published in Clinical Infectious Diseases and available online. The trends raise serious concerns about the effects on patient care, particularly for infections without effective alternative treatment options.

23 Apr 2015

IDT’s San Diego, California, manufacturing facility receives ISO 14001 certification

Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, has announced that its San Diego, California, manufacturing facility has attained ISO 14001:2004 certification for its environmental management systems. Now, both of IDT’s US manufacturing sites (Coralville, IA and San Diego, CA) have ISO 14001 certified environmental management systems.

From Integrated DNA Technologies 22 Apr 2015

Chemists working to develop 'greener' processes for discovering, developing medicines

Chemists funded by NIH's National Institute of General Medical Sciences are working to develop "greener" processes for discovering, developing and manufacturing medicines and other molecules with therapeutic potential, as well as compounds used in biomedical research.

22 Apr 2015

Bio-Rad grants Beckman Coulter exclusive distribution rights for access HIV and Hepatitis C assays

Bio-Rad is extending its agreement with Beckman Coulter and has named the company exclusive global distributor of Bio-Rad’s Access HIV combo assay and the Access hepatitis C virus (HCV) assay in select geographies...

From Beckman Coulter Diagnostics 21 Apr 2015

Kimberly-Clark's net sales decrease 4% to $4.7 billion in first quarter 2015

Kimberly-Clark Corporation today reported first quarter 2015 results and confirmed its previous guidance for full-year 2015 adjusted earnings per share.

21 Apr 2015

Manufacturing News and Research

Further Reading

T cell expansion technology: an interview with Alexander Malykhin, CVPF, University of Pennsylvania

GNC Holdings reports consolidated revenue of $670.2 million for first quarter 2015

HeartWare International's revenue increases 5% to $70.0 million in first quarter 2015

GE Healthcare’s first Innovation Village in the UK creates international interest from young life science businesses

Sangamo BioSciences to present data on ZFP Therapeutic platform at ASGCT meeting

Two UWM sensors offer protection against threat of contaminated water supplies

IDT opens molecular biology R&D facility in Redwood City

Stempeutics Research granted process patent in China for novel stem-cell based drug Stempeucel

Resverlogix, Hepalink announce equity investment and license agreement for RVX-208

Haemonetics' revenue for fourth quarter fiscal 2015 down 6%

OncoGenex terminates agreement with Teva, regains rights to custirsen

New study shows 'alarming rise' in costs of MS drugs over last 20 years

Glide's solid dose formulation of teriparatide achieves successful results in pre-clinical study

Glide's solid dose formulation of teriparatide achieves successful results in pre-clinical study

Physical forces can affect development of limbs in embryos

Rising shortages of key antibiotics raise serious concerns about effects on patient care

IDT’s San Diego, California, manufacturing facility receives ISO 14001 certification

Chemists working to develop 'greener' processes for discovering, developing medicines

Bio-Rad grants Beckman Coulter exclusive distribution rights for access HIV and Hepatitis C assays

Kimberly-Clark's net sales decrease 4% to $4.7 billion in first quarter 2015

New Approach Methodologies, the 3Rs and Multimodal Imaging in Preclinical Research - eBook eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®